Cutting-edge expertise joining forces with Servier
“This is extremely exciting! We have just gained access to AI and robotics technologies that will significantly energize our research.”
Christophe Thurieau, Executive Director of the Research Institute and Global Head of External Research at Servier
Signed on January 4 and January 8 respectively, the two collaborations are designed to harness the full potential of artificial intelligence and robotics applied to drug discovery.
With Iktos, a French leader in artificial intelligence and robotics, Servier will rely on an integrated platform combining generative AI and automated chemistry to design, synthesize and optimize small molecules across multiple biological targets, particularly in oncology and neurology. This approach accelerates the iterative scientific process between molecular design, chemical synthesis and biological evaluation of drug candidates. Servier will then take the lead on the clinical development of the selected programs.
At the same time, the collaboration with Insilico Medicine, a China/US-based pioneer in AI-driven drug discovery, is built around the company’s proprietary Pharma.AI platform. The objective is to rapidly identify new drug candidates against complex oncology targets, using algorithms capable of exploring biological and chemical spaces that have so far remained difficult to access.
“The success of Servier’s oncology programs makes us a credible partner for mutually beneficial collaborations. These partnerships illustrate the complementarity between next-generation AI technologies and Servier’s scientific, translational and clinical expertise.”
Fostering our strategic collaborations
These two partnerships illustrate how Servier has become an attractive player for strategic collaborations, providing access to some of the most promising technological tools available today. They also reflect the growing international footprint of Servier’s collaborations: in China with Insilico Medicine, and in France and Europe with Iktos. This global approach enables Servier to benefit from the best available solutions while strengthening the Group’s international development.